Research on Fetal Sex Differences in Predicting Spontaneous Preterm Birth Using Sera’s Proteomic Technology to be Presented at The 64th Annual Society for Reproductive Investigation Meeting
13 mars 2017 14h00 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, March 13, 2017 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced that research using Sera’s innovative proteomic technology platform that...
Sera Prognostics’ PreTRM® Named Edison Awards Finalist
09 févr. 2017 12h50 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, Feb. 09, 2017 (GLOBE NEWSWIRE) -- Sera Prognostics, a women’s heath company, today announced that PreTRM®, the first and only clinically-validated blood test that provides an early...
Research on Underlying Mechanisms of Pregnancy Complications and Medical Interventions Using Sera’s Proteomic Technology to be Presented at the Society for Maternal-Fetal Medicine’s 37th Annual Pregnancy Meeting
23 janv. 2017 15h08 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, Jan. 23, 2017 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced the presentation of ongoing research evaluating the underlying mechanisms of...
Sera Prognostics Enters into Agreement with LabCorp to be the Exclusive U.S. Distributor of PreTRM® Test
10 janv. 2017 07h00 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, Jan. 10, 2017 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a woman’s healthcare company, announced today that it has entered into a strategic collaboration with Laboratory Corporation...
Two Peer-Reviewed Publications Highlight Clinical Utility of PreTRM® Test
19 déc. 2016 09h00 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, Dec. 19, 2016 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced the recent publication of two reports showing significant clinical utility of...
Sera Prognostics to Present at 28th Annual Piper Jaffray Healthcare Conference
21 nov. 2016 07h00 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, Nov. 21, 2016 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced that Gregory C. Critchfield, M.D., M.S., Chairman and Chief Executive Officer,...
Sera Prognostics to Present at Ladenburg Thalmann 2016 Healthcare Conference
20 sept. 2016 11h36 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, Sept. 20, 2016 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced that Gregory C. Critchfield, M.D., M.S., Chairman and Chief Executive...
Landmark Study Published in American Journal of Obstetrics & Gynecology Validates New Blood Test as Objective, Predictive Tool for Preterm Birth Risk
10 mars 2016 07h00 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, March 10, 2016 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced that clinical validation data from the 5,501 patient Proteomic Assessment of...
Positive Clinical Validation Data for PreTRM® Test Presented at the Society for Maternal-Fetal Medicine’s 36th Annual Pregnancy Meeting
04 févr. 2016 15h15 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, Feb. 04, 2016 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced that results from the 5,501-patient Proteomic Assessment of Preterm Risk...
Sera Prognostics to Present at 34th Annual J.P. Morgan Healthcare Conference
21 déc. 2015 12h00 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, Dec. 21, 2015 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, todayannounced that Gregory C. Critchfield, M.D., M.S., Chairman and Chief Executive Officer,...